Navigation Links
Variable Blood Pressure a New Stroke Risk Factor?
Date:3/11/2010

Big ups and downs in readings may call for specific treatments, experts say

THURSDAY, March 11 (HealthDay News) -- Challenging established medical wisdom about blood pressure and stroke, new British research suggests that extremely variable blood pressure, and not just high blood pressure, can greatly increase a person's risk of stroke.

"Some people have very stable hypertension, in which case simple hypertension is all that matters, but variability and episodic hypertension is very common and matters much more than mean blood pressure in some patients," said Dr. Peter Rothwell, a professor of neurology at the University of Oxford and lead author of four papers in the March 13 issues of The Lancet and The Lancet Neurology.

One paper looked at high blood pressure and blood pressure variability in four groups of 2,000 people, each of who had minor strokes called transient ischemic attacks (TIAs), or "mini-strokes." These are warning signs of stroke risk.

They found that people with the greatest variation in systolic blood pressure (the higher of the 120/80 readings) over seven visits to their doctor were six times more likely to have a major stroke. People with the highest blood pressure readings were 15 times more likely to have a stroke.

"Under-diagnosis and under-treatment of hypertension is a major, seemingly intractable problem in all health-care systems," Rothwell said. "The new research shows that part of the problem is likely to have been under-recognition of the impact of variability in blood pressure on diagnosis in routine clinical practice in primary care. It shows that doctors have to make diagnoses on the basis of blood pressure measurements that vary substantially from visit to visit."

The message for doctors is that they have to change the way they view high blood pressure, he said.

"All current clinical guidelines encourage doctors to ignore variability and occasional high readings and to rely exclusively on the average blood pressure from multiple visits or 24-hour monitoring," Rothwell said. "The new research shows that increased variability in blood pressure, a high maximum blood pressure and episodic hypertension are associated with high risks of stroke and other vascular events, and emphasize that any comfort taken from the fact blood pressure is sometimes normal is false."

Other papers by Rothwell and his colleagues indicated that doctors should consider blood pressure variability when they choose among the many drugs now prescribed to control high blood pressure. A meta-analysis of 389 controlled trials found that effects on blood pressure variability explained why some classes of blood pressure drugs were more effective than others in preventing stroke. Another paper looked at the greater effectiveness of calcium channel blockers and thiazide diuretics vs. beta blockers in reducing stroke risk.

The result: "Calcium channel blockers and thiazide diuretics reduce [blood pressure] variability and beta blockers increase it," Rothwell concluded.

He called for development of new drugs that would stabilize and lower blood pressure at the same time. "Drugs that reduced variability without reducing average blood pressure should still prevent stroke and would be likely to be helpful in patients who cannot tolerate reductions in their average blood pressure," Rothwell theorized.

Variability can easily be measured when people visit their doctors, although "the fact that many people now monitor their blood pressure at home will be helpful in identifying variability," he said.

"I think these findings are very important and very compelling, and may revolutionize how we treat blood pressure in the future," said Dr. Philip B. Gorelick, director of the Center for Stroke Research at the University of Illinois, and a leading American expert on blood pressure and stroke. "They provide a very important foundation for change in future treatment."

Rothwell's findings already are starting to affect Gorelick's practice, he said.

"First, we may begin to screen patients with blood pressure measurements for variability to see if we can select for classes of drugs that reduce variability," Gorelick said. "And we can certainly adopt an at-home program to detect blood pressure variability, although within-visit variability seems to be a more important factor."

The findings may also affect the choice of the first drugs prescribed for blood pressure control, he said. "We would consider calcium channel blockers and diuretics for initial use," Gorelick said.

More information

There's more on spotting and controlling high blood pressure at the American Heart Association.



SOURCES: Peter Rothwell, M.D., Ph.D., professor, neurology, University of Oxford, England; Philip B. Gorelick, M.D., professor, neurology, and director, Center for Stroke Research, Chicago; March 13, 2010, The Lancet, The Lancet Neurology


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Variable Doses of Radiation Raise Safety Concerns for CT Procedures
2. Kinetic variable most useful for identifying malignant MRI-detected breast lesions identified
3. Milliman Survey Says Variable Annuity Guarantees Dominate Annuity Products
4. Sleep variables affecting school performance are different with each educational level
5. Milliman Survey Confirms Continued Dominance of Guarantees in Variable Annuity Retirement Income Products
6. Microgrid allows simultaneous study of multiple variables
7. Glycemic index values are variable, report researchers
8. New drug candidate reduces blood lipids
9. Mathematical innovation turns blood draw into information gold mine in Stanford study
10. Varicose Veins May Put Some at Risk for Dangerous Blood Clots
11. Years of Exposure to Traffic Pollution Raises Blood Pressure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... , June 23, 2016 , ... on Thursday, July 7, 2016 , , , , LOCATION: ... , , , , EXPERT PANELISTS:  , , , ... Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and ... The global pharmaceutical industry is witnessing an exceptional era. ...
Breaking Medicine Technology: